Intellia has leveraged its expertise in Crispr/Cas9 gene editing to advance a pipeline of in vivo and ex vivo therapies for diseases with high unmet medical needs. We believe Intellia's proprietary ...

Gene-edited crops in India, including drought-tolerant rice, nutritious bananas, and disease-resistant chilli, are enhancing ...

Cas9, the University of Bayreuth’s Biomaterials research group was able to bioengineer a common house spider to produce glowing red silk. Professor Thomas Scheibel and doctoral student Edgardo ...

The edited sheep contains no foreign DNA, distinguishing it from transgenic organisms and paving the way for regulatory ...

The CRISPR market is witnessing rapid growth due to its potential to transform gene therapy, diagnostics, and agriculture. With widespread research and commercial interest, the market is poised to ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Max Lian gets you up to date with some of the latest scientific news, including gene editing and electricity-storing cement ...

-Under the agreement, CRISPR Therapeutics will make an upfront payment of $25 million in cash and $70 million in equity to ...

Medable has launched a digital-first Long-Term Follow-Up (LTFU) model intended for cell and gene therapy (CGT) trials.